Genosity

Genosity is a biotechnology company focused on providing tools and services for clinical and research applications of genomics in healthcare space.

[Genosity @Genosity1]

We are excited about joining the @Invitae family, and looking forward to serving cancer patients world wide.
https://t.co/CQupRV83HH

[Genosity @Genosity1]

Our CEO. Dr. Marc Grodman will be on Genomics panel discussion being hosted by NYSE and EPAM. Topic: How Genomics can link processes from Bench to Bedside. Tune in at 11AM ET #Genomics
https://t.co/LNRCx4Vpba

[Genosity @Genosity1]

Thank you @gnomad_project for such a cool feature. Such a time savior to not go to clinvar to search separately .

[Genome Aggregation Database @gnomad_project]

The #gnomAD browser now displays more #ClinVar data!

New features include:
- ClinVar track includes all classifications
- Clinical significance, plus links to ClinVar, added to the variant table
- ClinVar details added to the variant page

[Genosity @Genosity1]

We are looking forward to working with @gemini_thera to support their clinical trial for age-related macular degeneration (AMD). https://t.co/Q0uCIgxfdQ
#raredisorders

[Genosity @Genosity1]

Genosity, Igentify Collaborate on Genetic Counseling Software, Ink Comarketing Deal https://t.co/H0aekAQlrP

[Genosity @Genosity1]

Improving patient access to precision medicine has been one of our main goals at Genosity. Partnering with Igentify is another step in that direction. https://t.co/X40q31pvcN

[Genosity @Genosity1]

An article published in @laboratorynews highlighting how @EPAMSYSTEMS has been a true partner in developing our comprehensive integrated genomic toolkit for labs interested in NGS testing. #Genomics https://t.co/1Fg94XXg7U

[James Hadfield @coregenomics]

I posted an MRD primer on my blog earlier today.

MRD in solid tumours is going prime-time with the likes of @archerdxinc @NateraOncology @Inivata @Genosity1 and now @illumina / @GrailBio

Let me know your thoughts...https://t.co/MgHblLuzlY

[Genosity @Genosity1]

https://t.co/V3W36TN8PS

[Genosity @Genosity1]

We are pleased to announce this collaboration with @OlinkProteomics . We cannot wait to offer multiomics services based on their innovative technology. https://t.co/BpuTkBWXVJ
#proteomics #ngs #Genomics

[Genosity @Genosity1]

Excited about this partnership with @PGDx_ to better enable our customers in advancing their precision medicine efforts. https://t.co/aNjyBUccw1

[Genosity @Genosity1]

Genosity Latest Entrant to Growing ctDNA Residual Disease Monitoring Market https://t.co/H29Tllr05j

[Genosity @Genosity1]

https://t.co/cUsKJQ930N

[Genosity @Genosity1]

Genosity’s Integrated Genomic Toolkit is a comprehensive solution that enables a clinical NGS lab to go from sample to result report. @EPAMSYSTEMS has been a great partner in this journey. #Genomics

[EPAM Systems @EPAMSystems]

Together, EPAM and Genosity built a leading research technology solution that reduces the obstacles that make it difficult for many labs and health systems leverage NGS #data: https://t.co/yQFbiK9pni #genomics

[Genosity @Genosity1]

Incorporation of genomic data in EHRs is so important for precision medicine to be successful. @ACMG has offered guidance on key elements to consider. #genomics #PrecisionMedicine #geneticdata

[ACMG @TheACMG]

What’s needed to get genomic medicine into the #EHR to improve patient care? Read the new ACMG Points to Consider on the interface of genomic information with the EHR @GIMJournal https://t.co/EOOZw0px0M #genetics #genomics #precisionmedicine

[Pharmacutical Daily @PharmacDaily]

Genosity to Investigate Genetics of Cardiac Amyloidosis https://t.co/gzHymdPU6I

[HCP Feed @FeedHcp]

Genosity to Investigate Genetics of Cardiac Amyloidosis,,https://t.co/C4VpE7lcIA,

[CRO Contract Res. @cro_bio]

Genosity to Investigate Genetics of Cardiac Amyloidosis: Genosity Inc. announced today that it has partnered with Columbia University Irving Medical Center to investigate genetic factors associated with wildtype cardiac amyloidosis a type of heart… https://t.co/uZ9o5OLdLc

[Genosity @Genosity1]

We are looking forward to collaborating with ⁦⁦⁦@Columbia⁩ University on this Cardiac Amyloidosis study. #genomics https://t.co/YWKNoAf7I6

[Genosity @Genosity1]

We are excited to meet you at our booth in the exhibit hall. Please stop by booth 2517 to meet our team at AMP.
#AMPath19